Cyclobenzaprine Hydrochloride
Product Images NDC 76420-019

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 76420-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7.5 mg 1000 Tablets (Cyclobenzaprine)

The text is describing information about packaged Cyclobenzaprine HCI Tablets of USP 7.5mg in three different quantities - 30, 60, and 90. The tablets are distributed by Innovida Pharmaceutique Corporation and contain federal law caution against dispensing without prescription. The tablets come batch-wise with lot number, expiration date, batch number, and standard instruction to keep out of reach of children and store in controlled room temperature. However, the source NDC code, description, and drug status remain the same for all the tablets.*

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.